Threats to private practice success include an increase in administrative burdens and IT costs.
Editor’s note: Check out the digital edition of APMA News for expert advice on how to minimize your risk of a ransomware attack, as well as cyber liability policy options.
Microemulsion Technology provides Podiatrists with better penetration and better results. With small particle size Formula 7®’s antibacterial and antifungal properties deliver the benefit of multiple products in a single tube or jar. The leader in Tolfnaftate Technology since 1986! Formula 7®is the first tolnaftate microemulsion utilizing soluble tolnaftate, the technology developed by the Tetra Corporation.
A bipartisan bill introduced in the U.S. House of Representatives would eliminate the upcoming Medicare physician payment cut.
Editor’s note: APMA submitted comments to CMS in response to proposed changes to the Medicare Physician Fee Schedule and the Quality Payment Program in 2023.
Power Diary now includes a complete Practice Operations Manual providing a set of policies and procedures that practices can configure to meet their businesses' needs, set standards for the workplace, and maintain professional operations. Developed by a team with over 50 years of industry experience, this game-changing feature is available exclusively to all Power Diary customers!
